Johns Hopkins researchers discovered that the little things a hospital can do goes a long way for the patient experience.
Johns Hopkins researchers discovered that the little things a hospital can do goes a long way for the patient.
In a recent study that examined 53 hospitals across the US, researchers found that the top-ranking hospitals for patient experiences of care shared 3 qualities: “a devotion to consistency, personal and focused interactions with patients, and a culture that demands involvement of all levels of caregivers and services.”
“It’s not just about getting the physicians involved, or the nurses,” lead study author Hanan Aboumatar, MD, MPH, an assistant professor of medicine at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Armstrong Institute for Patient Safety and Quality, said in a statement. “Everyone involved at the hospital, all the way up to top leadership, has to place a high priority on the needs of patients and their families.”
The Johns Hopkins research team sent letters and questionnaires to 169 chief executive officers of institutions listed on the December 2012 Hospital Consumer Assessment of Healthcare Providers and Systems survey, which ranks hospitals on terms of high-performance and improvement.
Among their many findings, the report indicated that:
The 53 hospitals that responded to the survey fairly represented the varying sizes and types of hospitals as a whole, where small, medium, and large hospitals could be divided almost evenly among the responses. Half of the responding hospitals were teaching hospitals and 37% of them were located in the Midwest.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Health Equity & Access Weekly Roundup: November 2, 2024
November 2nd 2024This week’s Center on Health Equity & Access highlights emphasize the role of social determinants of health in policy-making and underscore the importance of addressing rising costs and challenges employers face.
Read More